Characterization of patients that can continue conservative treatment for adenomyosis.

Miyagawa, Chiho; Murakami, Kosuke; Tobiume, Takako; Nonogaki, Takafumi; Matsumura, Noriomi

Miyagawa, Chiho; Murakami, Kosuke; Tobiume, Takako; Nonogaki, Takafumi; Matsumura, Noriomi.

Afiliação

Miyagawa C; Department of Obstetrics and Gynecology, Faculty of Medicine, Kindai University, 377-2 Ohnohigashi, Osaka-sayama, Osaka, 589-8511, Japan.
Murakami K; Department of Obstetrics and Gynecology, Osaka Red Cross Hospital, Osaka, Japan.
Tobiume T; Department of Obstetrics and Gynecology, Faculty of Medicine, Kindai University, 377-2 Ohnohigashi, Osaka-sayama, Osaka, 589-8511, Japan. kmurakami@med.kindai.ac.jp.
Nonogaki T; Department of Obstetrics and Gynecology, National Hospital Organization Osaka National Hospital, Osaka, Japan.
Matsumura N; Department of Obstetrics and Gynecology, Osaka Red Cross Hospital, Osaka, Japan.

BMC Womens Health ; 21(1): 431, 2021 12 28.

Article em En | MEDLINE | ID: mdl-34961515

Assuntos

Adenomiose; Endometriose; Adenomiose/cirurgia; Adulto; Tratamento Conservador; Feminino; Humanos; Histerectomia; Pessoa de Meia-Idade; Gravidez; Estudos Retrospectivos; Útero

Palavras-chave

Adenomyosis; Hormone; Hysterectomy; Risk factors; Treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Endometriose / Adenomiose Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged / Pregnancy Idioma: En Revista: BMC Womens Health Assunto da revista: SAUDE DA MULHER Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google